Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Current Deferred Revenue (2017 - 2026)

Catheter Precision's (VTAK) quarterly Current Deferred Revenue came in at $145000.0 in Q2 2026, up 15.08% quarter-over-quarter from $126000.0 in Q1 2026.

Analysis

Catheter Precision (VTAK) Current Deferred Revenue (2017 - 2026) Analysis & Trends

Catheter Precision (VTAK) has reported Current Deferred Revenue for 6 consecutive years, with $145000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $145000.0 in Q2 2026; TTM through Jun 2026 was $145000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $2.5 million, down 24.24% from the prior year.
  • Current Deferred Revenue was $145000.0 for Q2 2026 at Catheter Precision, up from $126000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $145000.0 in Q2 2026 and troughed at $126000.0 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn
10 Catheter Precision 553,488.01 -1.71 Mn 98,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145,000.00
Mar 31, 2026 126,000.00
Jun 30, 2021 1.79 Mn
Mar 31, 2021 1.78 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 1.73 Mn
Jun 30, 2020 1.86 Mn
Mar 31, 2020 1.96 Mn
Dec 31, 2019 3.30 Mn
Sep 30, 2019 1.92 Mn
Jun 30, 2019 2.04 Mn
Mar 31, 2019 1.95 Mn
Dec 31, 2018 1.72 Mn
Sep 30, 2018 1.75 Mn
Dec 31, 2017 1.71 Mn